The PE Ratio as of November 2024 (TTM) for Vertex Pharmaceuticals Incorporated (VRTX) is -237.35

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is -237.35. This represents a change of -1419.07% compared to the average of 17.99 of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (VRTX) Historical PE Ratio (quarterly & annually)

How has VRTX PE Ratio performed in the past?

The mean historical PE Ratio of Vertex Pharmaceuticals Incorporated over the last ten years is 5.52. The current -237.35 PE Ratio has changed -430043.40% with respect to the historical average. Over the past ten years (40 quarters), VRTX's PE Ratio was at its highest in in the June 2017 quarter at 443.13. The PE Ratio was at its lowest in in the September 2016 quarter at -126.50.

Vertex Pharmaceuticals Incorporated (VRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vertex Pharmaceuticals Incorporated (VRTX) Average PE Ratio

How has VRTX PE Ratio performed in the past?

The current PE Ratio of Vertex Pharmaceuticals Incorporated (VRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vertex Pharmaceuticals Incorporated (VRTX) PE Ratio vs. Peers

How is VRTX’s PE Ratio compared to its peers?

Vertex Pharmaceuticals Incorporated’s PE Ratio is less than BioMarin Pharmaceutical Inc. (37.97), less than Sarepta Therapeutics, Inc. (89.43), less than Seagen Inc. (-100.71), less than Alnylam Pharmaceuticals, Inc. (-94.78), less than Intellia Therapeutics, Inc. (-2.77), less than Editas Medicine, Inc. (-0.96), less than Beam Therapeutics Inc. (-14.38), less than Ginkgo Bioworks Holdings, Inc. (-0.58), less than BioNTech SE (-55.74), less than Moderna, Inc. (-7.12), less than Regeneron Pharmaceuticals, Inc. (17.14), less than Viking Therapeutics, Inc. (-58.83), less than PTC Therapeutics, Inc. (-7.34), less than Reata Pharmaceuticals, Inc. (-20.07), less than Intercept Pharmaceuticals, Inc. (-91.78), less than Krystal Biotech, Inc. (104.40), less than Madrigal Pharmaceuticals, Inc. (-14.57), less than CRISPR Therapeutics AG (-17.03), less than Caribou Biosciences, Inc. (-1.23), less than Verve Therapeutics, Inc. (-2.07),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (VRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (VRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.